Skip to main content
. Author manuscript; available in PMC: 2024 Feb 1.
Published in final edited form as: Clin Chem. 2023 Jan 4;69(1):48–55. doi: 10.1093/clinchem/hvac172

Table 3.

Association by study between apoB, LDL-C/apoB with CHD outcomes, per 1 SD increments adjusting for standard risk factors.

UKB WHS FHS
Variable Hazard ratio (95% CI) P value Hazard ratio (95% CI) P value Hazard ratio (95% CI) P value
Sex (male) 1.96 (1.89, 2.04) <0.001 2.28 (1.64, 3.17) <0.001
Age (per year) 1.07 (1.06, 1.07) <0.001 1.09 (1.08, 1.10) <0.001 1.05 (1.03, 1.07) <0.001
ApoB 1.24 (1.22, 1.27) <0.001 1.33 (1.20, 1.47) <0.001 1.24 (1.09, 1.42) 0.002
LDL-C/ApoB 1.00 (0.98, 1.02) 0.842 0.97 (0.87, 1.08) 0.540 0.78 (0.64, 0.94) 0.010
HDL-C 0.79 (0.77, 0.81) <0.001 0.90 (0.81, 1.01) 0.061 0.79 (0.65, 0.97) 0.022
Systolic Blood Pressure 1.19 (1.17, 1.21) <0.001 1.35 (1.23, 1.48) <0.001 1.17 (1.01, 1.36) 0.037
Blood pressure-lowering medications 1.53 (1.47, 1.59) <0.001 1.19 (0.93, 1.51) 0.160 1.17a (0.84, 1.63) 0.361
Diabetes 2.04 (1.87, 2.23) <0.001 4.23 (3.08, 5.82) <0.001 2.53 (1.70, 3.76) <0.001
Smoking 1.22 (1.18, 1.26) <0.001 1.77 (1.47, 2.13) <0.001 1.49 (1.09, 2.05) 0.014

Estimates for ApoB, LDL-C/ApoB, HDL-C, and systolic blood pressure are expressed per 1 SD.